Suppression of nitrative damage by metallothionein in diabetic heart contributes to the prevention of cardiomyopathy

被引:99
作者
Cai, Lu
机构
[1] Univ Louisville, Dept Med, Louisville, KY 40202 USA
[2] Univ Louisville, Dept Radiat Oncol, Louisville, KY 40202 USA
[3] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40202 USA
[4] Wenzhou Med Coll, Sch Pharm, Wenzhou 325035, Peoples R China
[5] Jilin Univ, Dept Hematol, Teaching Hosp 1, Changchun 130021, Peoples R China
[6] Jilin Univ, Dept Oncol, Teaching Hosp 1, Changchun 130021, Peoples R China
关键词
diabetic cardiomyopathy; metallothionein; reactive oxygen species; reactive nitrogen species; oxidative stress; nitrative stress; free radicals;
D O I
10.1016/j.freeradbiomed.2006.06.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic cardiomyopathy has become a major contributor to the increased mortality of diabetic patients. Although the development and progression of diabetic cardiomyopathy are considered to be associated with diabetes-derived oxidative stress, the precise mechanisms for and effectively preventive approaches to diabetic cardiomyopathy remain to be explored. Recent studies showed that reactive oxygen or nitrogen species (ROS/RNS) not only play a critical role in the initiation of diabetic cardiomyopathy, but also play an important role in physiological signaling. Therefore, this review will first discuss the dual roles of ROS/RNS in the physiological signaling and pathogenic remodeling leading to cardiomyopathy under diabetic conditions. The significant prevention of diabetic cardiomyopathy by metallothionein (NIT) as a potent and nonspecific antioxidant will be also summarized. It is clearly revealed that although dual roles of peroxynitrite-nitrated proteins have been indicated under both physiological and pathogenic conditions, suppression of nitrative damage by NIT in the diabetic heart is the major mechanism responsible for its prevention of diabetic cardiomyopathy. Finally the potential for clinical enhancement of the cardiac NIT expression to prevent or delay the occurrence of cardiomyopathy in diabetic patients will also be addressed. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:851 / 861
页数:11
相关论文
共 116 条
  • [31] The effect of diabetes on outcomes of patients with advanced-heart failure in the BEST trial
    Domanski, M
    Krause-Steinrauf, H
    Deedwania, P
    Follmann, D
    Ghali, JK
    Gilbert, E
    Haffner, S
    Katz, R
    Lindenfeld, J
    Lowes, BD
    Martin, W
    McGrew, F
    Bristow, MR
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (05) : 914 - 922
  • [32] ENZYMATIC DEFENSES OF THE MOUSE HEART AGAINST REACTIVE OXYGEN METABOLITES - ALTERATIONS PRODUCED BY DOXORUBICIN
    DOROSHOW, JH
    LOCKER, GY
    MYERS, CE
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (01) : 128 - 135
  • [33] Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation
    Du, XL
    Edelstein, D
    Rossetti, L
    Fantus, IG
    Goldberg, H
    Ziyadeh, F
    Wu, J
    Brownlee, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) : 12222 - 12226
  • [34] Peroxynitrite in the pathogenesis of Parkinson's disease and the neuroprotective role of metallothioneins
    Ebadi, M
    Sharma, SK
    Ghafourifar, P
    Brown-Borg, H
    El ReFaey, H
    [J]. NITRIC OXIDE, PT E, 2005, 396 : 276 - +
  • [35] Elgohary WG, 1998, CHEM-BIOL INTERACT, V115, P85
  • [36] Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes
    Esberg, LB
    Ren, J
    [J]. DIABETOLOGIA, 2003, 46 (10) : 1419 - 1427
  • [37] Metallothionein antagonizes aging-induced cardiac contractile dysfunction: role of PTP1B, insulin receptor tyrosine phosphorylation and Akt
    Fang, CX
    Doser, TA
    Yang, XP
    Sreejayan, N
    Ren, J
    [J]. AGING CELL, 2006, 5 (02) : 177 - 185
  • [38] Metallothionein alleviates cardiac contractile dysfunction induced by insulin resistance:: role of Akt phosphorylation, PTB1B, PPARγ and c-Jun
    Fang, CX
    Dong, F
    Ren, BH
    Epstein, PN
    Ren, J
    [J]. DIABETOLOGIA, 2005, 48 (11) : 2412 - 2421
  • [39] Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications
    Fang, ZY
    Prins, JB
    Marwick, TH
    [J]. ENDOCRINE REVIEWS, 2004, 25 (04) : 543 - 567
  • [40] A critical role for PPARα-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy:: Modulation by dietary fat content
    Finck, BN
    Han, XL
    Courtois, M
    Aimond, F
    Nerbonne, JM
    Kovacs, A
    Gross, RW
    Kelly, DP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (03) : 1226 - 1231